Antimicrobial Use, Resistance and Stewardship
A special issue of Antibiotics (ISSN 2079-6382). This special issue belongs to the section "Antibiotics Use and Antimicrobial Stewardship".
Deadline for manuscript submissions: closed (31 December 2021) | Viewed by 89364
Special Issue Editor
Interests: antimicrobial stewardship
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Antibiotic resistance is a major threat to public health worldwide, causing increased morbidity and mortality, prolonged stays in hospital, and significant increase in healthcare costs. Inappropriate use of antibiotics has increased the risk of emergence and spread of antimicrobial resistance (AMR), resulting in losing current effective antibiotics more quickly. Antimicrobial stewardship aims to promote and monitor the appropriateness of antimicrobials use, and to provide access to effective therapy.
This Special Issue seeks manuscript submissions (i.e., original qualitative and/or quantitative research, review articles, case reports and perspective ) on relevant antibiotic use, resistance, and stewardship topics in both primary and secondary healthcare settings, including: surveillance of antibiotic use and resistance initiatives, antimicrobial consumption and antimicrobial stewardship, interventions to promote appropriate antibiotic use, initiatives to establish and evaluate antimicrobial stewardships (antibiotic and antifungal), and evaluations of the impact of COVID-19 on antimicrobial consumption, antimicrobial resistance, and antimicrobial stewardship activities. Submissions from LMICs are especially encouraged.
Dr. Mamoon Aldeyab
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antibiotics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
Related Special Issue
- Antimicrobial Use, Resistance and Stewardship, 2nd Volume in Antibiotics (10 articles)